These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15936250

  • 1. Assessment of blinding in clinical trials.
    Henneicke-von Zepelin HH.
    Contemp Clin Trials; 2005 Aug; 26(4):512; author reply 514-5. PubMed ID: 15936250
    [No Abstract] [Full Text] [Related]

  • 2. Assessment of blinding in clinical trials.
    Bang H, Ni L, Davis CE.
    Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials.
    Nunn R.
    Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Experimental studies].
    Gili M, Lacalle JR, Velasco A.
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):52-7. PubMed ID: 2095906
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Moffet on the similarity of response to "active" and "sham" acupuncture.
    Cassidy CM.
    J Altern Complement Med; 2009 Mar; 15(3):209-10. PubMed ID: 19292651
    [No Abstract] [Full Text] [Related]

  • 10. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Dorhout Mees EJ.
    Ned Tijdschr Geneeskd; 2000 Nov 11; 144(46):2228. PubMed ID: 11103264
    [No Abstract] [Full Text] [Related]

  • 11. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A, Goldsmith C.
    Lancet; 2003 Dec 20; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract] [Full Text] [Related]

  • 12. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD, Awasthi S, Jeyaseelan L.
    Contemp Clin Trials; 2005 Aug 20; 26(4):459-68. PubMed ID: 16054578
    [Abstract] [Full Text] [Related]

  • 13. A new test of non-inferiority for anti-infective trials.
    Phillips KF.
    Stat Med; 2003 Jan 30; 22(2):201-12. PubMed ID: 12520557
    [Abstract] [Full Text] [Related]

  • 14. [Are placebo controlled studies on the proof of effectiveness of antidepressants necessary?].
    Möller HJ.
    Nervenarzt; 2004 May 30; 75(5):421-4. PubMed ID: 14999463
    [No Abstract] [Full Text] [Related]

  • 15. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study.
    James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK.
    Stat Med; 1996 Jul 15; 15(13):1421-34. PubMed ID: 8841652
    [Abstract] [Full Text] [Related]

  • 16. [Principles of controlled trials (author's transl)].
    Fink H.
    Arzneimittelforschung; 1978 Jul 15; 28(11a):2017-9. PubMed ID: 383091
    [Abstract] [Full Text] [Related]

  • 17. Panel discussion on clinical trials: design.
    Forssman L.
    Rheumatol Rehabil; 1978 Jul 15; Suppl():126-8. PubMed ID: 364603
    [No Abstract] [Full Text] [Related]

  • 18. Rank-based tests for non-inferiority and equivalence hypotheses in multi-centre clinical trials using mixed models.
    Rashid MM.
    Stat Med; 2003 Jan 30; 22(2):291-311. PubMed ID: 12520563
    [Abstract] [Full Text] [Related]

  • 19. The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials--a secondary analysis.
    Walach H, Sadaghiani C, Dehm C, Bierman D.
    BMC Med Res Methodol; 2005 Aug 18; 5():26. PubMed ID: 16109176
    [Abstract] [Full Text] [Related]

  • 20. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ, Hung HM.
    Stat Med; 2003 Jan 30; 22(2):227-38. PubMed ID: 12520559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.